March 25 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK:
LOSS ATTRIBUTABLE EXPECTED TO INCREASE TO HK$61 MILLION FOR FY
LOSS DUE TO HK$1.3 MILLION GOODWILL IMPAIRMENT IN FY, OTHERS
Further company coverage: 0455.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.